'

DFNS.net CBRN News Blog

0

Philippine Senate OKs bill prohibiting chemical weapons

GMA NEWS – Voting 15-0, the Senate on Monday approved on third and final reading a bill seeking to prohibit the development, production, stockpiling and use of chemical weapons in the country. Senate Bill...

0

Let’s get Otter here!

CBRN Academy/Swedish Rescue Training Centre AB and Lutra Associates Limited form partnership offering improved strategy, doctrine and equipment advice and realistic training for CBRNe, Hazmat, Civil and Disaster Relief …read more From:: CBRNe World...

0

CDC to deploy Ebola response team to help hospitals

CIDRAP NEWS – The US Centers for Disease Control and Prevention (CDC) has established an Ebola response team to immediately deploy to any hospital that has a confirmed Ebola patient, one of several steps...

0

History of Key Document in IAEA Probe Suggests Israeli Forgery

By Gareth PorterWASHINGTON, Oct 17 2014 (IPS) Western diplomats have reportedly faulted Iran in recent weeks for failing to provide the International Atomic Energy Agency with information on experiments on high explosives intended to...

0

Update: US R&D: Looking backwards to see forwards

In August the Pentagon’s second-highest official began describing a new effort to develop leap-ahead technologies that included developing a special report to serve as the guiding document for the push. That report is to...

0

Chimerix Speeding Up Brincidofovir Trials for Ebola

Chimerix reported today that it has received approval from the U.S. Food and Drug Administration to launch a Phase 2 clinical trial of Brincidofovir for the treatment of Ebola virus. Earlier this month, Chimerix...

0

Dual-Purpose Vaccines Effective Against Rabies and Ebola

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, this week announced a new license agreement aimed at advancing dual-purpose candidate vaccines to protect against rabies and...

0

Sarepta’s Ebola, Marburg Drugs Phase I Results Published

Sarepta Therapeutics, Inc. today announced the publication of results from two single ascending-dose studies that demonstrated no clinical or toxicologic safety concerns with the company’s drug candidates for the treatment of Ebola and Marburg...

0

NIAID Funds Multi-Institutional MRSA Research Initiative

Researchers at NYU Langone Medical Center will lead a consortium of five institutions on a $6.5 million contract from the National Institute of Allergy and Infectious Diseases (NIAID) directed at discovery of the fundamental...

0

GMU Biodfense faculty in the Washington Post

This week, GMU Biodefense Deputy Director Gregory Koblentz contributed to and Director Trevor Thrall was quoted this week in the Washington Post article titled “If news media had covered Ebola sooner, could latest outbreak...

0

Interspiro

Manufactures CBRN self-contained breathing apparatus (SCBA), airline systems and PAPR, respiratory protection equipment for contaminated air environments and high-performance underwater SCUBA systems for rescue divers. …read more From:: Fire Engineering (CBRN)

0

Kamaz/Minsk Wheel Tractor Plant merger talks stutter

The merger of Belarus heavy military vehicle manufacturing plant Minsk Wheel Tractor Plant (MZKT) into Russian technologies holding group Rostec appears to have been delayed by “differences of opinion” between the Russian and Belarusian...

0

The Manifestos of the Islamic State, Part II

The Manifestos of the Islamic State: Part I is available here. By Eric Goepner Potential recruits hear at least two different messages from the Islamic State. The first is a grievance-based message that can,...

0

How Presidents Arm and Disarm

The Obama administration has cut fewer nuclear weapons than any other post-Cold War administration. Click graph to view full size. By Hans M. Kristensen [updated] It’s a funny thing: the administrations that talk the...

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close